Vimarsana
Biggest News Aggregation in the World

Month Results News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Month Results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Month Results Today - Breaking & Trending Today

EVI Industries Reports Record Second Quarter Results - Vimarsana News

EVI Industries Reports Record Second Quarter Results

MIAMI--(BUSINESS WIRE)--Feb 9, 2024--

AstraZeneca advances scientific leadership in hematology at ASH 2023 - Vimarsana News

AstraZeneca advances scientific leadership in hematology at ASH 2023

CALQUENCE six-year follow-up data reinforce long-term benefit in chronic lymphocytic leukemia, and data across multiple hematology assets showcase breadth of promising early pipeline New,...

Thailand Board of Investment (BOI) Reports Steady Growth in 9-Month - Vimarsana News

Thailand Board of Investment (BOI) Reports Steady Growth in 9-Month

The Thailand Board of Investment (BOI) is pleased to share the accomplishments for the first nine months of 2023 and

Source: ryt9.com
Thailand Board of Investment (BOI) Reports Steady Growth in 9-Month Results, Attracting Foreign Investment and Fostering Key Industries - Vimarsana News

Thailand Board of Investment (BOI) Reports Steady Growth in 9-Month Results, Attracting Foreign Investment and Fostering Key Industries

The Thailand Board of Investment (BOI) is pleased to share the accomplishments for the first nine months of 2023 and introduce the new Automotive Industry Upgrade Measures. Chaired by Mr. Parnpree Bahiddha-Nukara, Deputy Prime Minister, the BOI will

VIVA23 Presents Outcomes of Late-breaking Science from Abbott's LIFE-BTK, RESOLV FIH Study, and IN.PACT AV Access Trial - Vimarsana News

VIVA23 Presents Outcomes of Late-breaking Science from Abbott's LIFE-BTK, RESOLV FIH Study, and IN.PACT AV Access Trial

The second round of late-breaking clinical trials were presented with results from three studies during the Vascular InterVentional Advances Conference, VIVA23, being held Oct. 30-Nov. 2 in Las Vegas, NV. Notably, results from Abbott’s LIFE-BTK randomized clinical trial (RCT) demonstrated that Esprit BTK (Abbott) reduces disease progression and helps improve medical outcomes compared to balloon angioplasty, the current state of care.